Ann: Appendix 4C - quarterly, page-4

Today Alcidion released its Appendix 4C quarterly cash flow report for the period ended 31 December 2019. The quarter saw Alcidion invest to accelerate growth in a favourable market, with new sales and marketing appointments and investments in evolving our platform. These were made in-line with our strategy to capitalise on the rapid shift occurring in the market globally, as healthcare providers look to technology to improve care.

Additionally, the outcome of the 2019 UK General Election has resulted in an advantageous operating environment for Alcidion, with policymakers promising significant investment to support the entire NHS in achieving digital maturity. We are actively accelerating our growth strategy in this market.

The quarter saw $3.5 million sold revenue added, with $2.1M of this to be recognised in FY2020. This brings total FY2020 revenue to $15.4M as at Q2, compared to $16.9M at the full year last year. Significant contract wins included a $500K deal with Global Digital Exemplar (GDE) Taunton and Somerset NHS Foundation Trust for Patientrack, and a ~$1.9M contract with early adopter Dartford and Gravesham NHS Trust, for our first implementation of Better’s OPENeP solution. These contracts provide important reference sites in the UK.

You can view the full Appendix 4C here.

Alcidion Managing Director Kate Quirke will be hosting a conference call at 11:00am AEDT this morning, to discuss the results and answer any questions investors may have. Dial-in details can be found in the Appendix 4C cover note. For those unable to join the call, an mp3 recording will be made available on our investor centre later today.